EU adds another rare blood condition as side effect of AstraZeneca shot, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The European Medicines Agency’s (EMA) safety committee said that capillary leak syndrome (CLS) must be added as a new side effect to labelling on AstraZeneca’s vaccine, known as Vaxzevria., The European Medicines Agency’s (EMA) safety committee said that capillary leak syndrome (CLS) must be added as a new side effect to labelling on AstraZeneca’s vaccine, known as Vaxzevria., , Read More